4//SEC Filing
Nicholson John 4
Accession 0001209191-17-066481
CIK 0000906709other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 6:28 PM ET
Size
7.5 KB
Accession
0001209191-17-066481
Insider Transaction Report
Form 4
Nicholson John
SVP & Chief Financial Officer
Transactions
- Award
Common Stock
2017-12-15+26,000→ 272,536 total - Award
Stock Option
2017-12-15+65,000→ 65,000 totalExercise: $56.90Exp: 2025-12-14→ Common Stock (65,000 underlying)
Footnotes (2)
- [F1]This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. These RSUs vest over three years in substantially equal quarterly installments based on continued service.
- [F2]This stock option vests over four years in equal monthly installments based on continued service.
Documents
Issuer
NEKTAR THERAPEUTICS
CIK 0000906709
Entity typeother
Related Parties
1- filerCIK 0001420766
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 6:28 PM ET
- Size
- 7.5 KB